Outcomes of Drug-Coated Balloon Versus Drug-Eluting Stent for In-Stent Restenosis and De-Novo Lesions: A Meta-Analysis of Randomized Controlled Trials. [PDF]
Moghadam AS +19 more
europepmc +1 more source
Short-term changes in interleukin 10 following drug-eluting stent placement in stable angina patients: Influence of hypertension. [PDF]
Albadri Z, Badri M, Almousali R.
europepmc +1 more source
Anemia and long-term outcomes after second-generation drug-eluting stent implantation: a retrospective cohort study of mortality and clinical restenosis. [PDF]
Ghorbanzadeh-Aghdam M +6 more
europepmc +1 more source
Drug-Eluting Stent Use in Percutaneous Coronary Interventions-A Narrative Review. [PDF]
Arh R, Balevski I, Granda S, Bevc S.
europepmc +1 more source
Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent Implantation. [PDF]
Park HW +22 more
europepmc +1 more source
Preclinical Assessment of a Novel Polymer-Free Hybrid Drug Eluting Stent. [PDF]
Wild L +8 more
europepmc +1 more source
Recurrent cardiac drug-eluting stent thrombosis due to antiphospholipid syndrome: a case report. [PDF]
Lin KK, Wine YY, Aye ST.
europepmc +1 more source
Long-Term Efficacy of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent for De Novo Large-Vessel Coronary Arteries. [PDF]
Masuda M +6 more
europepmc +1 more source
A case of progressive giant coronary aneurysm following first-generation drug-eluting stent implantation for chronic total occlusion-a case report and literature review. [PDF]
Li B, Han S, Li Z, Jin Q.
europepmc +1 more source
Nanocarrier SIroliMus-coated balloon-based percutaneous coronary intervention (PCI) versus drug-eluting stent (DES)-onLy PCI in patients with diabetes mellitus. [PDF]
Gitto M +20 more
europepmc +1 more source

